ERASCA, INC. (ERAS)
Erasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Patients with Metastatic Pancreatic Adenocarcinoma
Erasca Granted FDA Fast Track Designation for Pan-RAS Molecular Glue ERAS-0015 in Patients with Metastatic Pancreatic Adenocarcinoma
Datacentrex Secures Colocation Capacity and Set to Expand Mining Fleet by More Than 500 Additional ElphaPex DG2 Miners
Farmers & Merchants Bank of Long Beach Declares Third-Quarter Cash Dividend Payment of $28 Per Share
AIxCs RoboShare Secures New Short- and Long-Term Orders, Plans to Build North Americas Largest and Most Diverse Robot-Sharing Platform
Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Humacyte Confirms Plans for ATEV Supplemental BLA Filing for Dialysis Access Following FDA Discussions
European Footballs Corner-Kick Revolution: Goals Surge as Set Pieces Shape Title Races
Liminatus Pharma Engages Synex as Contract Research Organization to Support Phase 1/2a Clinical Development of CD19xCD22 bivalent CAR-T therapy
TTEC RealSkill™ Wins Gold for Best Use of AI for Learning at 2026 Brandon Hall Group™ HCM Excellence Awards
AZENTA ANNOUNCES LEADERSHIP TRANSITION
Rhythm Pharmaceuticals Announces MHLW Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity (HO) in Japan
Spruce Biosciences Announces Positive Pre-BLA Meetings with FDA and Confirms BLA Submission for TA-ERT on Track for Q4 2026
Gabelli To Host 4th Annual PFAS Symposium
Evolution Metals & Technologies Corp. Announces Preliminary Inclusion in Russell 3000® and Russell 2000® Indexes
Hawkeye Systems Rebrands as Hawkeye Digital, Inc.